Cargando…

Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice

OBJECTIVE: Friedreich's ataxia is an incurable inherited neurological disease caused by frataxin deficiency. Here, we report the neuroreparative effects of myeloablative allogeneic bone marrow transplantation in a humanized murine model of the disease. METHODS: Mice received a transplant of flu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kemp, Kevin C., Hares, Kelly, Redondo, Juliana, Cook, Amelia J., Haynes, Harry R., Burton, Bronwen R., Pook, Mark A., Rice, Claire M., Scolding, Neil J., Wilkins, Alastair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947591/ https://www.ncbi.nlm.nih.gov/pubmed/29534309 http://dx.doi.org/10.1002/ana.25207

Ejemplares similares

Cytokine therapy‐mediated neuroprotection in a Friedreich's ataxia mouse model
por: Kemp, Kevin C., et al.
Publicado: (2017)

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia
por: Kemp, Kevin C., et al.
Publicado: (2022)

Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia
por: Kemp, Kevin C., et al.
Publicado: (2016)

Erratum to: ‘Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia’
por: Kemp, Kevin C., et al.
Publicado: (2016)

Mesenchymal Stem Cells Restore Frataxin Expression and Increase Hydrogen Peroxide Scavenging Enzymes in Friedreich Ataxia Fibroblasts
por: Kemp, Kevin, et al.
Publicado: (2011)

Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum
por: Redondo, Juliana, et al.
Publicado: (2014)

Reductions in kinesin expression are associated with nitric oxide-induced axonal damage
por: Redondo, Juliana, et al.
Publicado: (2015)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Epigenetic-based therapies for Friedreich ataxia
por: Sandi, Chiranjeevi, et al.
Publicado: (2014)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Identification of telomere dysfunction in Friedreich ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2015)

Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy
por: Sandi, Chiranjeevi, et al.
Publicado: (2013)

Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells
por: Kemp, Kevin C., et al.
Publicado: (2018)

Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells
por: Kemp, Kevin, et al.
Publicado: (2017)

Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis
por: Sarkar, Pamela, et al.
Publicado: (2018)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis
por: Redondo, Juliana, et al.
Publicado: (2018)

Otoneurological Abnormalities in Patients with Friedreich's Ataxia
por: Zeigelboim, Bianca Simone, et al.
Publicado: (2016)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Characterization of the retinal pigment epithelium in Friedreich ataxia
por: Crombie, Duncan E., et al.
Publicado: (2015)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018)

Heart disease in Friedreich’s ataxia
por: Hanson, Emily, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Two Cases of Friedreich’s Ataxia
por: Stephenson, F. H.
Publicado: (1897)

Respiratory Function in Friedreich’s Ataxia
por: Vinante, Elena, et al.
Publicado: (2022)

Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020)

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro
por: Redondo, Juliana, et al.
Publicado: (2017)

Friedreich Ataxia: Multidisciplinary Clinical Care
por: Lynch, David R, et al.
Publicado: (2021)

Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
por: Sarkar, Pamela, et al.
Publicado: (2021)

Cell fusion in the brain: two cells forward, one cell back
por: Kemp, Kevin, et al.
Publicado: (2014)

FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia
por: Chutake, Yogesh K., et al.
Publicado: (2015)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
por: Cissé, Cheick A. K., et al.
Publicado: (2021)

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis
por: Hares, Kelly, et al.
Publicado: (2021)

MutLα Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia
por: Ezzatizadeh, Vahid, et al.
Publicado: (2014)

'Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich's ataxia'
por: Abeti, R, et al.
Publicado: (2016)

DNA methylation in Friedreich ataxia silences expression of frataxin isoform E
por: Rodden, Layne N., et al.
Publicado: (2022)

Cellular, Molecular and Functional Characterisation of YAC Transgenic Mouse Models of Friedreich Ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2014)

Anaesthesia for a patient with Friedreich's ataxia
por: Ganesan, Ilango
Publicado: (2011)

Hepatic mitochondrial dysfunction in Friedreich Ataxia
por: Stüwe, Sven H, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kduic1v734cuj6lpsfo2612he7